# Aerosol L9-NC and Temozolomide in Ewing's Sarcoma

> **NCT00492141** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Ewing's Sarcoma

## Interventions

- **DRUG:** Temozolomide
- **DRUG:** L9-NC

## Key facts

- **NCT ID:** NCT00492141
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-05
- **Final completion:** 2009-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492141, "Aerosol L9-NC and Temozolomide in Ewing's Sarcoma". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00492141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*